Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

EBCC 2022: Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years

EBCC 2022: Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival...

Webinar: Quality management in breast cancer surgery

Webinar: Quality management in breast cancer surgery

EBCC 2022: Ultrasound-guided surgery is quicker, less painful and more effective for treating early form of breast cancer

EBCC 2022: Ultrasound-guided surgery is quicker, less painful and more effective for treating early form of breast...

EBCC 2022: Researchers find changes in blood proteins up to two years before breast cancer diagnosis

EBCC 2022: Researchers find changes in blood proteins up to two years before breast cancer diagnosis

EBCC 2022: Personalised breast cancer screening could improve cancer survival and reduce overdiagnosis

EBCC 2022: Personalised breast cancer screening could improve cancer survival and reduce overdiagnosis

EBCC 2022: Gradual increase in daily activity with psychological therapies can improve mental health for cancer patients and survivors

EBCC 2022: Gradual increase in daily activity with psychological therapies can improve mental health for cancer...

FDA grants accelerated approval to mirvetuximab soravtansine-gynx for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or peritoneal cancer

FDA grants accelerated approval to mirvetuximab soravtansine-gynx for FRα positive, platinum-resistant epithelial...

NICE recommends cabozantinib for previously treated advanced hepatocellular carcinoma

NICE recommends cabozantinib for previously treated advanced hepatocellular carcinoma

FDA approves brentuximab vedotin in combination with chemotherapy for paediatric patients with classical Hodgkin lymphoma

FDA approves brentuximab vedotin in combination with chemotherapy for paediatric patients with classical Hodgkin...

Untreatable cancers can now be treated by substituting a gene in patients’ immune cells

Untreatable cancers can now be treated by substituting a gene in patients’ immune cells

More from ecancer